Penbrook Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Penbrook Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$75K	Sell	69,500 -46,008	-40%	-$49.5K	0.08%	104
2016 Q2	$131K	Sell	115,508 -5,150	-4%	-$8.31K	0.14%	101
2016 Q1	$216K	Sell	120,658 -4,150	-3%	-$6.88K	0.24%	91
2015 Q4	$272K	Sell	124,808 -525	-0.4%	-$731	0.28%	91
2015 Q3	$107K	Sell	125,333 -1,250	-1%	-$1.42K	0.11%	109
2015 Q2	$181K	Sell	126,583 -10,411	-8%	-$25.5K	0.17%	97
2015 Q1	$445K	Sell	136,994 -750	-0.5%	-$2.56K	0.4%	83
2014 Q4	$438K	Hold	137,744	–	–	0.4%	86
2014 Q3	$1.12M	Sell	137,744 -1,600	-1%	-$13.1K	1.03%	38
2014 Q2	$1.46M	Sell	139,344 -139,819	-50%	-$1.19M	1.29%	29
2014 Q1	$1.93M	Buy	279,163 +139,169	+99%	+$825K	0.92%	43
2013 Q4	$664K	Buy	+139,994	New	+$655K	0.64%	63

Other funds holding BSTG

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TSP

Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Penbrook Management's BSTG Position: Q3 2016 in Review

Penbrook Management reduced its Biostage, Inc. Common Stock (BSTG) stake by 40% in Q3 2016, selling an estimated $49.5K and leaving 69,500 shares worth $75K. The position accounts for 0.08% of the portfolio, ranked #104.

Penbrook Management first reported a position in BSTG in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.93M in Q1 2014. 26 funds tracked by Wall St. Rank hold BSTG as of Q3 2016.

Penbrook Management held 69,500 shares of Biostage, Inc. Common Stock worth $75K as of Q3 2016.
Penbrook Management sold 46,008 Biostage, Inc. Common Stock shares in Q3 2016, an estimated $49.5K.
Biostage, Inc. Common Stock made up 0.08% of Penbrook Management's portfolio in Q3 2016, its #104 holding.
Penbrook Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and has held it in 12 quarters since.
Penbrook Management's Biostage, Inc. Common Stock position peaked at $1.93M in Q1 2014.
26 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2016.

Based on Penbrook Management's 13F filing for Q3 2016, filed 27 Oct 2016.